8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
West Pharmaceutical ($WST) filed an 8‑K (Item 2.02) on Feb 12, 2026 announcing Q4 & full‑year 2025…
Filed with the SEC on · Summarized by InvestorsBot
West Pharmaceutical ($WST) filed an 8‑K (Item 2.02) on Feb 12, 2026 announcing Q4 & full‑year 2025 results; press release attached as Exhibit 99.1. Investors should review release for revenue, EPS, guidance and call details. 🗓️📈 #earnings #pharma
Item 2.02 reports results of operations and financial condition announced Feb 12, 2026; the press release is incorporated by reference (Ex. 99.1). Could be market‑moving—monitor share activity and management commentary. 📰🔍 $WST #healthcare #earnings
The 8‑K itself contains no financial figures — full Q4/FY2025 numbers and any 2026 outlook are in the attached press release (Ex. 99.1). Read Exhibit 99.1 for specifics. 💡📄 $WST #pharma #WST